Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

INVITROCUE LIMITED

INVESTOR PRESENTATION - INVITROCUE LIMITED

ASX:IVQ

INVITROCUE LIMITED

Health Care

Invitrocue Limited (IVQ, formerly Bunuru Corporation Limited) is involved in research and experimental development on biotechnology, life and medical sciences. Currently IVQ has Cell-based assaying business and Digital pathology business. Invitrocue currently operates in Singapore and China and is listed on Australian Securities Exchange under the ticker IVQ. Former Names Intellect Holdings Limited (IHG) on 13/02/2009; Ellect Holdings Limited (EHG), 06/11/2012; EHG Corporation Limited (EHG), 04/06/2015; Bunuru Corporation Limited (BUN), 22/01/2016;

Read more

Market Cap

34.71m

Price at Close

$0.06

4w avg. Volume

0.00

4w avg. Turnover

$0.00

Announcements
announcementt+2 movementdate
  • ACE-2 HiMice Platform for COVID19

    Progress Report

  • 0.00%

    24 Sep 2020

0.00%

24 Sep 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    31 Jul 2020

0.00%

31 Jul 2020
  • Operational updates

    Progress Report

  • 0.00%

    21 Jun 2020

0.00%

21 Jun 2020
  • 4C Commentaries and Management Updates

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    01 May 2020

0.00%

01 May 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    29 Apr 2020

0.00%

29 Apr 2020
  • Onco-PDO cancer test successfully registered for CE Mark

    Progress Report · Market sensitive

  • 0.00%

    21 Apr 2020

0.00%

21 Apr 2020
  • Initial Director's Interest Notice - Chow Yee Koh

    Shareholder Details

  • 0.00%

    04 Mar 2020

0.00%

04 Mar 2020
  • Final Director's Interest Notice - Geoffrey Thomas

    Shareholder Details

  • 0.00%

    04 Mar 2020

0.00%

04 Mar 2020
  • Board changes

    Company Administration

  • 0.00%

    03 Mar 2020

0.00%

03 Mar 2020
  • Joint Venture MOU for Brazilian and Latin American market

    Progress Report · Market sensitive

  • 0.00%

    11 Feb 2020

0.00%

11 Feb 2020
Market Data

Current Price

$0.06

52WK HIGH

$0.06

52WK LOW

$0.06

1YR RETURN

0.00%

1YR RETURN VS. SECTOR

-27.69%

90 DAY RETURN

0.00%

ASX RANK

1,217

/2,010

SECTOR RANK

31

/47

SHARES OUTSTANDING

578.49m
ASX:IVQ

INVITROCUE LIMITED

Health Care

Invitrocue Limited (IVQ, formerly Bunuru Corporation Limited) is involved in research and experimental development on biotechnology, life and medical sciences. Currently IVQ has Cell-based assaying business and Digital pathology business. Invitrocue currently operates in Singapore and China and is listed on Australian Securities Exchange under the ticker IVQ. Former Names Intellect Holdings Limited (IHG) on 13/02/2009; Ellect Holdings Limited (EHG), 06/11/2012; EHG Corporation Limited (EHG), 04/06/2015; Bunuru Corporation Limited (BUN), 22/01/2016;

Read more

Market Cap

34.71m

Price at Close

$0.06

4w avg. Volume

0.00

4w avg. Turnover

$0.00

ASX:IVQ is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.